BACKGROUND. Intrahepatic and extrahepatic factors are utilized by
Determinants of survival in patients with unresectable colorectal liver metastases
β Scribed by Dr. Alfred E. Chang; Seth M. Steinberg; Mary Culnane; Donald E. White
- Publisher
- John Wiley and Sons
- Year
- 1989
- Tongue
- English
- Weight
- 501 KB
- Volume
- 40
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
β¦ Synopsis
Prognostic indicators in 67 patients with unresectable colorectal liver metastases were analyzed. These patients were identified to have isolated hepatic metastases after extensive radiological evaluation and demonstrated good performance status without evidence of liver failure. Univariate analysis revealed 6 of 22 factors that were associated with survival: alkaline phosphatase (AP), lactic dehydrogenase (LDH), occult intra-abdominal extrahepatic disease, percent hepatic replacement by tumor (PHR), sex, and carcinoembryonic antigen (CEA). A multivariate analysis identified two independent factors that jointly influenced survival: AP and PHR. Patients with an AP 3175 U/liter had a greater than threefold relative risk of dying compared with patients with AP 5 175 U/liter (P = 0.0001). Patients with PHR I1 or I11 (25-75%, >75%) also had a greater than threefold relative risk of dying compared with patients with PHR 1 (<25%; P = 0.0074). Our patient population is typical of that being entered into trials examining experimental therapies. Alkaline phosphatase and extent of liver involvement by tumor are significant prognostic indicators that should be accounted for in such studies.
π SIMILAR VOLUMES
## Abstract ## Background Portal vein embolization (PVE) increases the resectability of initially unresectable colorectal liver metastases (CLM). This study evaluated long-term survival in patients with CLM who underwent hepatectomy following PVE. ## Methods In a retrospective analysis patients
Clinical features and their prognostic value were evaluated in 83 colorectal cancer patients with liver metastasis. The clinical features analysed included presenting symptoms and signs, liver function tests, extent of liver involvement, associated extrahepatic tumor growth, and physical condition o